XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statement of Changes in Redeemable Noncontrolling Interest and Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Total Stockholders’ Equity
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Redeemable Noncontrolling Interest
Outstanding shares, beginning balance (in shares) at Jul. 31, 2022     952,163,896        
Stockholders' equity, beginning balance at Jul. 31, 2022   $ 4,625,599 $ 96 $ 838,460 $ (169,365) $ 3,956,408  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss)   245,848       245,848  
Currency translation adjustment   (29,571)     (29,571)    
Exercise of stock options, net of repurchased shares (in shares)     151,108        
Exercise of stock options, net of repurchased shares   766   1,061   (295)  
Stock-based compensation (in shares)     76,624        
Stock-based compensation   10,192   10,192      
Outstanding shares, ending balance (in shares) at Oct. 31, 2022     952,391,628        
Stockholders' equity, ending balance at Oct. 31, 2022   4,852,834 $ 96 849,713 (198,936) 4,201,961  
Outstanding shares, beginning balance (in shares) at Jul. 31, 2022     952,163,896        
Stockholders' equity, beginning balance at Jul. 31, 2022   4,625,599 $ 96 838,460 (169,365) 3,956,408  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) $ 889,956            
Currency translation adjustment 16,906            
Outstanding shares, ending balance (in shares) at Apr. 30, 2023     954,260,050        
Stockholders' equity, ending balance at Apr. 30, 2023   5,592,422 $ 96 901,447 (152,459) 4,843,338  
Outstanding shares, beginning balance (in shares) at Oct. 31, 2022     952,391,628        
Stockholders' equity, beginning balance at Oct. 31, 2022   4,852,834 $ 96 849,713 (198,936) 4,201,961  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss)   293,677       293,677  
Currency translation adjustment   42,429     42,429    
Exercise of stock options, net of repurchased shares (in shares)     446,852        
Exercise of stock options, net of repurchased shares   9,218   9,754   (536)  
Stock-based compensation (in shares)     60,702        
Stock-based compensation   10,131   10,131      
Shares issued for Employee Stock Purchase Plan (in shares)     229,114        
Shares issued for Employee Stock Purchase Plan   5,363   5,363      
Outstanding shares, ending balance (in shares) at Jan. 31, 2023     953,128,296        
Stockholders' equity, ending balance at Jan. 31, 2023   5,213,652 $ 96 874,961 (156,507) 4,495,102  
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 350,431 350,431       350,431  
Currency translation adjustment $ 4,048 4,048     4,048    
Exercise of stock options, net of repurchased shares (in shares)     1,014,218        
Exercise of stock options, net of repurchased shares   14,210   16,405   (2,195)  
Stock-based compensation (in shares)     117,536        
Stock-based compensation   10,081   10,081      
Outstanding shares, ending balance (in shares) at Apr. 30, 2023     954,260,050        
Stockholders' equity, ending balance at Apr. 30, 2023   5,592,422 $ 96 901,447 (152,459) 4,843,338  
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023 957,344,162   957,344,162        
Stockholders' equity, beginning balance at Jul. 31, 2023 $ 5,987,440 5,987,440 $ 96 938,910 (141,006) 5,189,440 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss)   332,527       332,527 5
Currency translation adjustment   (36,353)     (36,353)    
Acquisition of noncontrolling interest (in shares)     2,499,993        
Acquisition of noncontrolling interest   112,075   112,075     25,217
Exercise of stock options, net of repurchased shares (in shares)     331,358        
Exercise of stock options, net of repurchased shares   7,412   8,123   (711)  
Stock-based compensation (in shares)     32,761        
Stock-based compensation   8,316   8,316      
Outstanding shares, ending balance (in shares) at Oct. 31, 2023     960,208,274        
Stockholders' equity, ending balance at Oct. 31, 2023   6,411,417 $ 96 1,067,424 (177,359) 5,521,256 25,222
Outstanding shares, beginning balance (in shares) at Jul. 31, 2023 957,344,162   957,344,162        
Stockholders' equity, beginning balance at Jul. 31, 2023 $ 5,987,440 5,987,440 $ 96 938,910 (141,006) 5,189,440 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 1,040,169            
Currency translation adjustment $ (15,801)            
Exercise of stock options, net of repurchased shares (in shares) 2,047,000            
Outstanding shares, ending balance (in shares) at Apr. 30, 2024 962,268,657   962,268,657        
Stockholders' equity, ending balance at Apr. 30, 2024 $ 7,171,253 7,171,253 $ 96 1,102,684 (156,807) 6,225,280 24,933
Outstanding shares, beginning balance (in shares) at Oct. 31, 2023     960,208,274        
Stockholders' equity, beginning balance at Oct. 31, 2023   6,411,417 $ 96 1,067,424 (177,359) 5,521,256 25,222
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss)   325,635       325,635 (108)
Currency translation adjustment   32,080     32,080    
Exercise of stock options, net of repurchased shares (in shares)     828,799        
Exercise of stock options, net of repurchased shares   3,906   5,359   (1,453)  
Stock-based compensation (in shares)     119,004        
Stock-based compensation   8,601   8,601      
Shares issued for Employee Stock Purchase Plan (in shares)     155,419        
Shares issued for Employee Stock Purchase Plan   5,961   5,961      
Outstanding shares, ending balance (in shares) at Jan. 31, 2024     961,311,496        
Stockholders' equity, ending balance at Jan. 31, 2024   6,787,600 $ 96 1,087,345 (145,279) 5,845,438 25,114
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Net income/(loss) 382,110 382,291       382,291 (181)
Currency translation adjustment $ (11,528) (11,528)     (11,528)    
Exercise of stock options, net of repurchased shares (in shares)     872,081        
Exercise of stock options, net of repurchased shares   4,446   6,895   (2,449)  
Stock-based compensation (in shares)     85,183        
Stock-based compensation   8,448   8,448      
Shares issued for Employee Stock Purchase Plan (in shares)     (103)        
Shares issued for Employee Stock Purchase Plan   (4)   (4)      
Outstanding shares, ending balance (in shares) at Apr. 30, 2024 962,268,657   962,268,657        
Stockholders' equity, ending balance at Apr. 30, 2024 $ 7,171,253 $ 7,171,253 $ 96 $ 1,102,684 $ (156,807) $ 6,225,280 $ 24,933